BO
$1.17
+0.03
(+2.72%)
As of Oct 5, 2026, 5:11 PM EDT
Price history
Bon Natural Life (BON) is trading up at $1.17 (+2.72%), as of the latest quote. It operates in the Health Care sector.
IPO: June 24, 2021 · $5.00 offering · NASDAQ · View IPO details →
Bon Natural Life revenue & net income history (FY2019–FY2025)
RevenueNet income
| FY2019Sep 2019 | FY2020Sep 2020 | FY2021Sep 2021 | FY2022Sep 2022 | FY2023Sep 2023 | FY2024Sep 2024 | FY2025Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $16.4M | $18.2M | $25.5M | $29.9M | $29.5M | $23.8M | $18.7M |
| Growth (year over year) | — | +11.1% | +39.9% | +17.3% | −1.3% | −19.2% | −21.7% |
| Gross profit | $5.28M | $5.20M | $7.11M | $9.42M | $8.84M | $7.11M | $3.88M |
| Gross margin | 32.2% | 28.6% | 27.9% | 31.5% | 29.9% | 29.8% | 20.8% |
| Operating income | $3.18M | $3.47M | $5.40M | $6.60M | $5.94M | $1.87M | −$1.62M |
| Operating margin | 19.4% | 19.0% | 21.2% | 22.1% | 20.1% | 7.9% | −8.7% |
| Net income | $2.57M | $3.03M | $4.59M | $6.24M | $4.60M | $398.2K | −$1.99M |
| Net margin | 15.7% | 16.6% | 18.0% | 20.9% | 15.6% | 1.7% | −10.7% |
| EPS (diluted) | $125.00 | $145.00 | $170.00 | $185.75 | $124.92 | $4.14 | −$0.72 |
| Balance sheet | |||||||
| Cash and equivalents | — | $53.1K | $1.90M | $840.9K | $112.8K | $80.5K | $6.27M |
| Total assets | — | $25.2M | $36.4M | $37.3M | $46.6M | $61.8M | $85.2M |
| Total liabilities | — | $14.2M | $9.88M | $7.16M | $10.6M | $17.4M | $27.2M |
| Long-term debt | — | $2.48M | $2.17M | $189.8K | $871.4K | $970.1K | $842.8K |
| Shareholders' equity | $7.26M | $10.5M | $26.0M | $29.6M | $35.5M | $43.9M | $57.6M |
| Cash flow | |||||||
| Operating cash flow | $7.10M | $2.64M | $4.05M | −$187.1K | −$616.9K | −$7.72M | $141.1K |
| Capital expenditure | $213.6K | $31.9K | $51.9K | $27.7K | $61.9K | $7.05K | $6.83K |
| Free cash flow | $6.89M | $2.61M | $4.00M | −$214.8K | −$678.8K | −$7.73M | $134.3K |
From Bon Natural Life's 20-F and 6-K filings with the SEC; its fiscal year ends in September. Each period shows the latest figure the company has reported for it, including restatements. Per-share figures are per ordinary share, which is not always the share traded in the US: an ADS can stand for several, or for part of one. Filings on SEC EDGAR →
About Bon Natural Life
- Headquarters
- Shaanxi, China From SEC filings, Oct 2026
Recent News (1)
Other Health Care companies to compare with BON
- BNTC Benitec Biopharma Inc
- BNTX BioNTech
- BOLD Boundless Bio
- BOLT Bolt Biotherapeutics
- BRKR Bruker
- BTMD Biote Corp Class a
- BTSG Brightspring Health Services Inc
- BVS Bioventus Class a Inc